In February, Congress finally took action to rein in PBMs via the Consolidated Appropriations Act of 2026. It included reforms like the delinking of PBM compensation from the price of a drug in ...

Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If ...

Grow Therapy's Series D funding was led by TCV and Growth Equity at Goldman Sachs Alternatives, with participation from BCI, Menlo Ventures, Sequoia, SignalFire and Transformation Capital.

Many healthcare AI startups are changing the way they charge for their technology, moving away from flat subscription rates and toward pricing linked to the financial impact of their tools. Investors ...

Health data company Health Gorilla filed a motion to dismiss a lawsuit from Epic and several healthcare providers alleging inappropriate access to nearly 300,000 patient records. The case highlights ...

An experimental drug that Theravance Biopharma touted as a potential first-in-class medicine for multiple system atrophy has failed a Phase 3 study, triggering a corporate shakeup that ends this ...

Healthcare affordability is known to be one of the most painful paradoxes in the United States. Despite spending more on healthcare per capita than any other country, for most Americans good health ...

CMS’ new ACCESS model, slated to begin on July 1, aims to shift traditional Medicare fee-for-service toward value-based care by tying payments to patient outcomes and encouraging tech-enabled, ...

We welcome outside perspective and so invite your thoughts and stories on MedCityNews.com alongside our own reporters through the MedCity Influencers program. MedCityNews.com is the leading source for ...

Parachute Health has raised a Series B round on the heels of another fundraise earlier this year for a total of $15 million. Insight Venture Partners became the latest investors to back the business ...

Giving healthcare teams powerful AI tools without training undermines their ability to use potentially system-changing tools safely and effectively.

The healthcare startup world gained a new unicorn on Tuesday, with Silicon Valley-based Solace Health closing a $130 million Series C funding round that took its valuation to more than $1 billion.